Its ligand PD-L1, present on tumour cells and tumour stroma, binds PD-1 on activated tumour-targeting T-cells, which inhibits T-cell proliferation and cytokine production, promoting tumour self-tolerance [68,69,70]. This evidence concerns the gene CD274 and neoplasm.